Alnylam Pharmaceuticals Market Sentiment

Alnylam Pharmaceuticals Inc

ALNYNASDAQ

Trade with Public

$227.28

2.180.97%

Últ. Act.: Oct 22, 7:42 PM

$225.00

-0.1-0.04%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ganancias: Beneficios de Q3 2026 dentro de 6 días de ahora en jue oct 29th, antes de la apertura del mercado

Conferencia telefónica: Conferencia telefónica programada para dentro de 6 días a las 8:30 a. m.

Haz clic para ver el webcast

Alnylam Pharmaceuticals Market Sentiment

Market sentiment signals for Alnylam Pharmaceuticals (ALNY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 7.7% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

—

Avg Consensus PT

$418

+85.6%

Highest Price Target

$583

+159.1%

Citigroup

Lowest Price Target

$253

+12.4%

Wells Fargo

Short Interest

7.7%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 15, 2026	UBS	Joon Lee—	+57.3%	$550 → $354	Assumes	Buy
Oct 14, 2026	Citigroup	Eric Joseph—	+42.2%	$340 → $320	Maintained	Buy
Oct 14, 2026	Wells Fargo	Derek Archila—	+12.4%	$256 → $253	Maintained	Equal-Weight
Oct 8, 2026	RBC Capital	Luca Issi—	+53.3%	$350 → $345	Maintained	Outperform
Sep 30, 2026	JP Morgan	Jessica Fye—	+64.0%	$375 → $369	Maintained	Overweight
Sep 21, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+102.2%	$455 → $455	Maintained	Buy
Sep 8, 2026	Jefferies	Faisal Khurshid—	+15.6%	$230 → $260	Maintained	Hold
Sep 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+102.2%	$455 → $455	Maintained	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+41.3%	$318	Initiate	Outperform
Aug 14, 2026	Wells Fargo	Derek Archila—	+13.8%	$316 → $256	Maintained	Equal-Weight
Aug 4, 2026	Truist Securities	Danielle Brill—	+40.0%	$410 → $315	Maintained	Buy
Aug 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+102.2%	$485 → $455	Maintained	Buy
Aug 3, 2026	Raymond James	Martin Auster—	+86.7%	$420 → $420	Upgrade	Outperform→Strong Buy
Aug 3, 2026	Citigroup	Eric Joseph—	+51.1%	$380 → $340	Maintained	Buy
Aug 3, 2026	Barclays	Eliana Merle—	+100.0%	$527 → $450	Maintained	Overweight
Jul 31, 2026	JP Morgan	Jessica Fye—	+66.7%	$400 → $375	Maintained	Overweight
Jul 31, 2026	RBC Capital	Luca Issi—	+55.6%	$445 → $350	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+33.3%	$400 → $300	Maintained	Equal-Weight
Jul 31, 2026	Oppenheimer	Kostas Biliouris—	+55.6%	$500 → $350	Maintained	Outperform
Jul 31, 2026	Wells Fargo	Derek Archila—	+40.4%	$377 → $316	Maintained	Equal-Weight
Jul 31, 2026	Stifel	Paul Matteis—	+41.3%	$444 → $318	Maintained	Buy
Jul 31, 2026	Chardan Capital	Keay Nakae—	+88.9%	$425 → $425	Maintained	Buy
Jul 30, 2026	Needham	Joseph Stringer—	+58.7%	$510 → $357	Maintained	Buy
Jul 22, 2026	JP Morgan	Jessica Fye—	+77.8%	$420 → $400	Maintained	Overweight
Jul 14, 2026	B of A Securities	Tazeen Ahmad—	+82.2%	$460 → $410	Maintained	Buy